Mitochondrially encoded ATP synthase 6 pseudogene 17 (MTATP6P17)

MT-ATP6 pseudogene 17 (MTATP6P17) is a human pseudogene that shares sequence similarity with MT-ATP6, the gene encoding a subunit of mitochondrial ATP synthase. However, pseudogenes such as MTATP6P17 do not produce functional proteins and have no known biological or pathological function. They are categorized as non-coding elements, often arising from duplication or retrotransposition of protein-coding genes but acquiring disabling mutations so that they cannot produce an active product. This gene should not be confused with the functional MT-ATP6 gene, which encodes a subunit of ATP synthase and is clinically associated with mitochondrial diseases such as Leigh syndrome. No pharmacological agents or clinical interventions target MTATP6P17, and it is not included in therapeutic target databases. The identification as a pseudogene is confirmed by expert resources such as NCBI Gene and GeneCards, where it is explicitly labeled "Pseudogene" and no protein coding, disease, or drug associations are indicated. MT-ATP6 pseudogene 17 is not a therapeutic or functional molecular target, but a pseudogene with no recognized protein product, biological activity, or disease relevance. The main source of confusion is the similarity to the functional MT-ATP6 gene, but the suffix "pseudogene" and the lack of function are critical distinguishing features.

Other names

MT-ATP6 pseudogene 17Mitochondrially encoded ATP synthase 6 pseudogene 17MTATP6P17

None.